SFM
TNGX icon

Sphera Funds Management’s Tango Therapeutics TNGX Stock Holding History

Sphera Funds Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.19M Sell
343,563
-201,000
-37% -$2.8M 1.14% 26
2025
Q4 		$4.82M Buy
+544,563
New +$4.69M 0.93% 45
2024
Q4 		– Sell
-50,000
Closed -$385K – 131
2024
Q3 		$385K Buy
+50,000
New +$477K 0.06% 109

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Sphera Funds Management's TNGX Position: Q1 2026 in Review

Sphera Funds Management reduced its Tango Therapeutics (TNGX) stake by 37% in Q1 2026, selling an estimated $2.8M and leaving 343,563 shares worth $7.19M. The position accounts for 1.14% of the portfolio, ranked #26.

Sphera Funds Management first reported a position in TNGX in Q3 2024 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Sphera Funds Management held 343,563 shares of Tango Therapeutics worth $7.19M as of Q1 2026.
  • Sphera Funds Management sold 201,000 Tango Therapeutics shares in Q1 2026, an estimated $2.8M.
  • Tango Therapeutics made up 1.14% of Sphera Funds Management's portfolio in Q1 2026, its #26 holding.
  • Sphera Funds Management first reported a position in Tango Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.